• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
OPT

OPTHEA LIMITED

0.00% ! 60.0¢
Market Cap $820.7M  !

Opthea Limited is an Australia-based clinical-stage biopharmaceutical company. The... Opthea Limited is an Australia-based clinical-stage biopharmaceutical company. The Company is engaged in developing novel therapies to address the unmet need in the treatment of prevalent and progressive retinal diseases, including wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME). Its lead product candidate, sozinibercept (OPT-302), is being evaluated in two pivotal Phase 3 clinical trials for use in combination with standard-of-care anti-VEGF-A monotherapies for the treatment of wet AMD and DME. The Company has also manufactured OPT-302 for use in Phase III clinical trials, conducts activities to support the commercialization of the product and expanded its management team in the United States to facilitate broader oversight and execution of its Phase III program. Its development activities are based on an intellectual property portfolio covering key targets (Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3).More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
OPT 10/09/25 76 20K
10/09/25 Last post  slambo Comments Created with Sketch.  76  Views Created with Sketch.  20K 
OPT 05/09/25 0 361
05/09/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  361 
OPT 05/09/25 0 190
05/09/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  190 
OPT 29/08/25 0 496
29/08/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  496 
OPT 22/08/25 2 1.0K
22/08/25 Last post  yehudi Comments Created with Sketch.  2  Views Created with Sketch.  1.0K 
OPT 21/08/25 0 400
21/08/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  400 
OPT 20/08/25 5 1.8K
20/08/25 Last post  Paul Dong Comments Created with Sketch.  5  Views Created with Sketch.  1.8K 
OPT
The DFA Discussion
2
19/08/25 106 49K
19/08/25 Last post  Ollie3039 Comments Created with Sketch.  106  Views Created with Sketch.  49K 

See All Discussions arrow Created with Sketch.

Timeline

S&P DJI Announces September 2025 Quarterly Rebalance
05 Sep 17:09
 
Application for quotation of securities - OPT
05 Sep 16:47
 
Preliminary Final Report
29 Aug 19:16
 
Ceasing to be a substantial holder
22 Aug 08:15
 
Becoming a substantial holder
21 Aug 18:52
 
Corporate Update Investor Call
20 Aug 09:02
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
60.0¢
Change
0.000(0.00%)
Mkt cap ! $820.7M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
OPT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.